U.S. Department of Health and Human Services

 Contact Info

Tel: 301-496-4201
Email: robert.jensen@nih.gov

 Select Experience

  • M.D.University of Chicago1964
  • B.S.Washington State University1960

 Related Links


    Robert T. Jensen, M.D.

    Section Chief, Gastrointestinal Cell Biology SectionDigestive Disease Branch
    • Cell Biology/Cell Signaling
    • Clinical Research
    • Molecular Pharmacology/Toxicology


    A selection of recent and significant publications can be viewed below.

    Wang J, Pappas-Brown V, Englund PT, Jensen RE. TbKAP6, a Mitochondrial HMG box-Containing Protein in Trypanosoma brucei, Is the First Trypanosomatid KAP protein Essential for kDNA Replication and Maintenance. Eukaryot Cell. 2014 Jul; (2014 Jul). [Full Text/Abstract]
    Uchida M, Ito T, Nakamura T, Hijioka M, Igarashi H, Oono T, Kato M, Nakamura K, Suzuki K, Takayanagi R, Jensen RT. Pancreatic Stellate Cells and CX3CR1: Occurrence in Normal Pancreas and Acute and Chronic Pancreatitis and Effect of Their Activation by a CX3CR1 Agonist. Pancreas. 2014 Jul; 43 (43; 2014 Jul; 5):708-19. [Full Text/Abstract]
    Nielsen K, Andersen T, Jensen R, Nielsen JH, Chorkendorff I. An open-source data storage and visualization back end for experimental data. J Lab Autom. 2014 Apr; 19 (19; 2; 2014 Apr):183-90. [Full Text/Abstract]
    Moody TW, Chan DC, Mantey SA, Moreno P, Jensen RT. SR48692 inhibits non-small cell lung cancer proliferation in an EGF receptor-dependent manner. Life Sci. 2014 Mar 28; 100 (2014 Mar 28; 100; 1):25-34. [Full Text/Abstract]
    Lesurtel M, Nagorney DM, Mazzaferro V, Jensen RT, Poston GJ. When should a liver resection be performed in patients with liver metastases from neuroendocrine tumours? A systematic review with practice recommendations. HPB (Oxford). 2014 Mar 17; 17 (2014 Mar 17; 17; 1):17-22. [Full Text/Abstract]
    Bhatt SP, Kim YI, Wells JM, Bailey WC, Ramsdell JW, Foreman MG, Jensen RL, Stinson DS, Wilson CG, Lynch DA, Make BJ, Dransfield MT. FEV1/FEV6 to Diagnose Airflow Obstruction. Comparisons with Computed Tomography and Morbidity Indices. Ann Am Thorac Soc. 2014 Mar; 11 (2014 Mar; 3; 11):335-41. [Full Text/Abstract]
    Ito T, Igarashi H, Nakamura K, Sasano H, Okusaka T, Takano K, Komoto I, Tanaka M, Imamura M, Jensen RT, Takayanagi R, Shimatsu A. Epidemiological trends of pancreatic and gastrointestinal neuroendocrine tumors in Japan: a nationwide survey analysis. J Gastroenterol. 2014 Feb 6; 50 (2014 Feb 6; 50; 1):58-64. [Full Text/Abstract]
    Nakamura T, Ito T, Uchida M, Hijioka M, Igarashi H, Oono T, Kato M, Nakamura K, Suzuki K, Jensen RT, Takayanagi R. PSCs and GLP-1R: occurrence in normal pancreas, acute/chronic pancreatitis and effect of their activation by a GLP-1R agonist. Lab Invest. 2014 Jan; 94 (94; 2014 Jan; 1):63-78. [Full Text/Abstract]
    Ramos-Álvarez I, Moreno-Villegas Z, Martín-Duce A, Sanz R, Aparicio C, Portal-Núñez S, Mantey SA, Jensen RT, González N. Human BRS-3 receptor: functions/role in cell signaling pathways and glucose metabolism in obese or diabetic myocytes. Peptides. 2014 Jan; 51 (2014 Jan; 51):91-9. [Full Text/Abstract]
    Di Florio A, Sancho V, Moreno P, Delle Fave G, Jensen RT. Gastrointestinal hormones stimulate growth of Foregut Neuroendocrine Tumors by transactivating the EGF receptor. Biochim Biophys Acta. 2013 Mar; 1833 (2013 Mar; 1833; 3):573-82. [Full Text/Abstract]
    Uehara H, Hocart SJ, González N, Mantey SA, Nakagawa T, Katsuno T, Coy DH, Jensen RT. The molecular basis for high affinity of a universal ligand for human bombesin receptor (BnR) family members. Biochem Pharmacol. 2012 Oct 1; 84 (7; 2012 Oct 1; 84):936-48. [Full Text/Abstract]
    Norton JA, Fraker DL, Alexander HR, Jensen RT. Value of surgery in patients with negative imaging and sporadic Zollinger-Ellison syndrome. Ann Surg. 2012 Sep; 256 (2012 Sep; 256; 3):509-17. [Full Text/Abstract]
    Moody TW, Osefo N, Nuche-Berenguer B, Ridnour L, Wink D, Jensen RT. Pituitary adenylate cyclase-activating polypeptide causes tyrosine phosphorylation of the epidermal growth factor receptor in lung cancer cells. J Pharmacol Exp Ther. 2012 Jun; 341 (2012 Jun; 341; 3):873-81. [Full Text/Abstract]
    Jensen RT, Cadiot G, Brandi ML, de Herder WW, Kaltsas G, Komminoth P, Scoazec JY, Salazar R, Sauvanet A, Kianmanesh R, Barcelona Consensus Conference participants. ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes. Neuroendocrinology. 2012; 95 (95; 2012; 2):98-119. [Full Text/Abstract]
    Kulke MH, Anthony LB, Bushnell DL, de Herder WW, Goldsmith SJ, Klimstra DS, Marx SJ, Pasieka JL, Pommier RF, Yao JC, Jensen RT, North American Neuroendocrine Tumor Society (NANETS). NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas. Pancreas. 2010 Aug; 39 (6; 39; 2010 Aug):735-52. [Full Text/Abstract]
    González N, Nakagawa T, Mantey SA, Sancho V, Uehara H, Katsuno T, Jensen RT. Molecular basis for the selectivity of the mammalian bombesin peptide, neuromedin B, for its receptor. J Pharmacol Exp Ther. 2009 Oct; 331 (2009 Oct; 1; 331):265-76. [Full Text/Abstract]
    Hoffmann KM, Tapia JA, Berna MJ, Thill M, Braunschweig T, Mantey SA, Moody TW, Jensen RT. Gastrointestinal hormones cause rapid c-Met receptor down-regulation by a novel mechanism involving clathrin-mediated endocytosis and a lysosome-dependent mechanism. J Biol Chem. 2006 Dec 8; 281 (281; 2006 Dec 8; 49):37705-19. [Full Text/Abstract]
    Norton JA, Fraker DL, Alexander HR, Gibril F, Liewehr DJ, Venzon DJ, Jensen RT. Surgery increases survival in patients with gastrinoma. Ann Surg. 2006 Sep; 244 (244; 2006 Sep; 3):410-9. [Full Text/Abstract]
    Moody TW, Sun LC, Mantey SA, Pradhan T, Mackey LV, Gonzales N, Fuselier JA, Coy DH, Jensen RT. In vitro and in vivo antitumor effects of cytotoxic camptothecin-bombesin conjugates are mediated by specific interaction with cellular bombesin receptors. J Pharmacol Exp Ther. 2006 Sep; 318 (318; 2006 Sep; 3):1265-72. [Full Text/Abstract]
    Mantey SA, Coy DH, Entsuah LK, Jensen RT. Development of bombesin analogs with conformationally restricted amino acid substitutions with enhanced selectivity for the orphan receptor human bombesin receptor subtype 3. J Pharmacol Exp Ther. 2004 Sep; 310 (310; 3; 2004 Sep):1161-70. [Full Text/Abstract]
    Moody TW, Mantey SA, Pradhan TK, Schumann M, Nakagawa T, Martinez A, Fuselier J, Coy DH, Jensen RT. Development of high affinity camptothecin-bombesin conjugates that have targeted cytotoxicity for bombesin receptor-containing tumor cells. J Biol Chem. 2004 May 28; 279 (2004 May 28; 279; 22):23580-9. [Full Text/Abstract]
    Tapia JA, García-Marin LJ, Jensen RT. Cholecystokinin-stimulated protein kinase C-delta kinase activation, tyrosine phosphorylation, and translocation are mediated by Src tyrosine kinases in pancreatic acinar cells. J Biol Chem. 2003 Sep 12; 278 (278; 37; 2003 Sep 12):35220-30. [Full Text/Abstract]
    Abou-Saif A, Gibril F, Ojeaburu JV, Bashir S, Entsuah LK, Asgharian B, Jensen RT. Prospective study of the ability of serial measurements of serum chromogranin A and gastrin to detect changes in tumor burden in patients with gastrinomas. Cancer. 2003 Jul 15; 98 (98; 2; 2003 Jul 15):249-61. [Full Text/Abstract]
    Pace A, García-Marin LJ, Tapia JA, Bragado MJ, Jensen RT. Phosphospecific site tyrosine phosphorylation of p125FAK and proline-rich kinase 2 is differentially regulated by cholecystokinin receptor type A activation in pancreatic acini. J Biol Chem. 2003 May 23; 278 (278; 21; 2003 May 23):19008-16. [Full Text/Abstract]
    Peghini PL, Annibale B, Azzoni C, Milione M, Corleto VD, Gibril F, Venzon DJ, Delle Fave G, Bordi C, Jensen RT. Effect of chronic hypergastrinemia on human enterochromaffin-like cells: insights from patients with sporadic gastrinomas. Gastroenterology. 2002 Jul; 123 (123; 2002 Jul; 1):68-85. [Full Text/Abstract]
    Tokita K, Hocart SJ, Coy DH, Jensen RT. Molecular basis of the selectivity of gastrin-releasing peptide receptor for gastrin-releasing peptide. Mol Pharmacol. 2002 Jun; 61 (6; 2002 Jun; 61):1435-43. [Full Text/Abstract]
    Shojamanesh H, Gibril F, Louie A, Ojeaburu JV, Bashir S, Abou-Saif A, Jensen RT. Prospective study of the antitumor efficacy of long-term octreotide treatment in patients with progressive metastatic gastrinoma. Cancer. 2002 Jan 15; 94 (94; 2; 2002 Jan 15):331-43. [Full Text/Abstract]